Latest Western Troy Cap Res (WTCRF) Headlines Nadim Wakeam

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Western Troy Cap Res (WTCRF) Headlines

Nadim Wakeam Resigns as Director of Western Troy
Marketwire - Mon Feb 10, 3:31PM CST
Western Troy Capital Resources (TSX VENTURE : WRY) (Western Troy or the Company) announced today that Nadim Wakeam has decided to resign from Western Troy, as of February 7, 2014.

Edward G. Thompson Resigns as Director of Western Troy and Other Junior Exploration Companies
Marketwire - Thu Jan 02, 11:15AM CST
Western Troy Capital Resources (TSX VENTURE: WRY)(OTCQX: WTCRF) (Western Troy or the Company) announced today that Edward G. Thompson has decided to resign from all of his junior exploration company directorships, including Western Troy, as of January 1, 2014.

Western Troy Stakes Claims on Gold Prospects in Nunavut and Quebec, Niobium/Rare Earths in Quebec
ACCESSWIRE - Mon Sep 16, 2:03PM CDT
September 16, 2013, Toronto, Ontario - Western Troy Capital Resources (TSX Venture: WRY, US-OTC: WTCRF) (Western Troy or the Company) announced today that over the summer, it has made application for site staked claims on two gold prospects in Nunavut. It has map-staked claims on a gold prospect in the Rouyn-Noranda (Abitibi) region of Quebec, and has map-staked claims on a Niobium/Rare Earths prospect in Southern Quebec.

King's Bay Gold Corporation reports that the 3rd and final anniversary payment under an option agreement has been made on 6 unpatented mining claims at the Menary Gold Project
ACCESSWIRE - Wed Aug 28, 3:05PM CDT
King's Bay Gold Corporation (TSX.V: KBG) (the "Corporation") is pleased to report that it has completed the 3rd and final anniversary payment on an option agreement dated August 23rd, 2010 with Luc Gagnon (the "Vendor") for 6 unpatented mining claims located at the Menary Gold Project. The 6 unpatented mining claims are located in the Townships of Menary and Claxton and are contiguous to the overall Menary Gold Project land package that currently consists of 1 patented and 17 unpatented mining claims for approximately 1,728 hectares. As a result of issuing the 3rd and final anniversary payment of 500,000 common shares, the Corporation now has a 100% interest in the 6 unpatented claims. As per the option agreement of August 23rd, 2010, the Vendor retains a Net Smelter Return (NSR) of 2%. The Corporation has a right to repurchase 1% of this NSR at any time for $1,000,000.

Western Troy Grants Options
ACCESSWIRE - Thu Jul 25, 8:19AM CDT
July 25, 2012, Toronto, Ontario - Western Troy Capital Resources (TSX Venture: WRY, US-OTC: WTCRF) has granted 150,000 options to two directors, one of whom is an officer. These options have been granted pursuant to Western Troy's Stock Option Plan. They will have a term of five years and are exercisable at a price of 10 cents per share.

Western Troy Announces the Passing of Executive Chairman Stanley Mourin
ACCESSWIRE-TNW - Fri Apr 26, 4:20PM CDT
April 26, 2013, Toronto, Ontario - Western Troy Capital Resources (TSX Venture: WRY, US-OTC: WTCRF) (Western Troy or the Corporation) management is saddened to announce today the passing of Executive Chairman and CFO, Stanley Mourin. Stanley passed peacefully in his sleep this morning after a short stay in palliative care. He is survived by his wife Barbara and daughter Ainsley.

Western Troy Announces Annual General Meeting to be Held May 1, 2013
ACCESSWIRE-TNW - Wed Apr 03, 1:55PM CDT
April 3, 2013, Toronto, Ontario - Western Troy Capital Resources (TSX Venture: WRY, US-OTC: WTCRF) (Western Troy or the Corporation) announced today it will hold its annual meeting of shareholders at 11:30 a.m. on Wednesday, May 1, 2013, at the Toronto Board of Trade, 77 Adelaide Street West, Toronto, Ontario. Among other administrative items, the following agenda items are to be put to a vote of the shareholders:

Western Troy Provides Update on Exploration Activities and Files Statement of Defense to the Counterclaim of GENIVAR Regarding the MacLeod Lake Feasibility Study
ACCESSWIRE-TNW - Fri Dec 21, 2:28PM CST
December 21, 2012, Toronto, Ontario - Western Troy Capital Resources (TSX Venture: WRY, US-OTC: WTCRF) (Western Troy or the Company) today filed a Statement of Defense to the Counterclaim of GENIVAR, Inc. The document has been filed with the Superior Court of Justice (Toronto). As previously announced, Western Troy filed a Statement of Claims on Friday, September 28, 2012, against GENIVAR Inc. for $3.3 million and certain of their professional managers for $2.2 million for professional negligence in work performed on a feasibility study for Western Troy's MacLeod Lake Copper/Molybdenum Project. On December 7, 2012, Western Troy received a Statement of Defense and Counterclaim from GENIVAR, Inc. That document asserted a counterclaim of $450,000 against Western Troy. Western Troy's filing of today asserts a defense to the counterclaim. The full text of all today's filing will be available soon on Western Troy's Website, www.westerntroy.com. Western Troy's Statement of Claims and GENIVAR's Statement of

Western Troy Capital Resources, Inc. (WTCRF) Stock Research Links

WTCRF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading